Published: 2018-12-08

Articles

COST- EFFECTIVENESS OF INTENSIVE LIPID LOWERING THERAPY WITH 80 MG OF ATORVASTATIN, VERSUS 10 MG OF ATORVASTATIN, FOR SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE IN CANADA

Monika Wagner, Mireille Goetghebeur, Elizabeth Merikle, Ankur Pandya, Paula Chu, Douglas CA Taylor
Abstract 247 | PDF Downloads 146
PDF

ACCESS AND INTENSITY OF USE OF PRESCRIPTION ANALGESICS AMONG OLDER MANITOBANS

Cheryl A Sadowski, Anita G Carrie, Ruby E Grymonpre, Colleen J Metge, Philip St.John
Abstract 181 | PDF Downloads 88
PDF

Innovations in Pharmacology - CSPT 2009 Conference Abstracts

Saskatoon, Saskatchewan
Abstract 129 | PDF Downloads 107
PDF

VALIDITY OF PERINATAL PHARMACOEPIDEMIOLOGIC STUDIES USING DATA FROM THE RAMQ ADMINISTRATIVE DATABASE

Anick Bérard, Anaïs Lacasse
Abstract 294 | PDF Downloads 176
PDF

CLINICAL EVALUATION OF DE MARCO FORMULA AS AN ADJUNCTIVE THERAPY FOR INFECTED ISCHEMIC DIABETIC FOOT: A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL

Héctor Álvarez Duarte, José I Fernández Montequín, Martha M Fors López, José Hernández Carretero, Miriam Mahia Vilas, Milagros García Mesa
Abstract 148 | PDF Downloads 76
PDF

THE UNINTENDED (AND COSTLY) EFFECTS DUE TO THE INTRODUCTION OF AN UNRESTRICTED REIMBURSEMENT POLICY FOR ATYPICAL ANTIPSYCHOTIC MEDICATIONS IN A CANADIAN PUBLIC PRESCRIPTION DRUG PROGRAM: 1996/97 TO 2005/06

Daria J O’Reilly, Ron A Goeree, Jean-Eric Tarride, Colleen Janes, Patrick S Parfrey
Abstract 143 | PDF Downloads 74
PDF

VIDENCE AND VALUES: REQUIREMENTS FOR PUBLIC REIMBURSEMENT OF DRUGS FOR RARE DISEASES - A CASE STUDY IN ONCOLOGY

Michael Drummond, Bill Evans, Jacques LeLorier, Pierre Karakiewicz, Douglas Martin, Peter Tugwell, Stuart MacLeod
Abstract 518 | PDF Downloads 208
PDF

Evidence and Values: Requirements for Public Reimbursement of Drugs for Rare Diseases- A Case Study in Oncology- Reply

Andreas Laupacis
Abstract 149 | PDF Downloads 82
PDF

A Critical Review of: “Pediatric fatalities associated with over the counter (nonprescription) cough and cold medications”

Ran D. Goldman
Abstract 86 | PDF Downloads 54
PDF

ETHYLGLUCURONIDE AND ETHYLSULFATE IN MECONIUM TO ASSESS GESTATIONAL ETHANOL EXPOSURE: PRELIMINARY RESULTS IN TWO MEDITERRANEAN COHORTS

Simona Pichini, Luca Morini, Emilia Marchei, Ilaria Palmi, Maria Concetta Rotolo, Federica Vagnarelli, Oscar Garcia-Algar, Oriol Val, Piergiorgio Zuccaro
Abstract 224 | PDF Downloads 133
PDF

WERE OUR FOREBEARS AWARE OF PRENATAL ALCOHOL EXPOSURE AND ITS EFFECTS? A REVIEW OF THE HISTORY OF FETAL ALCOHOL SPECTRUM DISORDER

James L Sanders
Abstract 495 | PDF Downloads 391
PDF

THE RELATION BETWEEN THEORY OF MIND AND EXECUTIVE FUNCTIONS IN CHILDREN WITH FETAL ALCOHOL SPECTRUM DISORDERS

Carmen Rasmussen, Katy Wyper, Victoria Talwar
Abstract 1299 | PDF Downloads 524
PDF